Pure Global
NCT06376058

Chloroprocaine 1% Versus Ropivacaine 0,75% During Cesarean Section

Intrathecal Use of Chloroprocaine 1% and Ropivacaine 0,75% During Elective Cesarean Section. A Comparative Study
Aretaieion University Hospital·ClinicalTrials.gov·drugRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Cesarean Section,Local Anesthetic
Drug/Device/Intervention
Chloroprocaine 1% Injectable Solution
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Aretaieion University Hospital
Location
Athens, Greece
Timeline & enrollment
Phase
N/A
Start date
Jan 10, 2024
End date
Jan 10, 2026
Enrollment
60 participants
Primary outcome

Time from spinal anesthesia to T10 block (min),Time from spinal anesthesia to T4 block (min),Time of spinal anesthesia to Bromage =3,level of sensory block every 3 min,level of sensory block every 15 min,highest level of sensory block,time from spinal anesthesia to highest level of sensory block,duration of sensory block,pain at surgical incision,pain at neonatal delivery,pain at peritoneal manipulation,pain at Post Anesthesia Care Unit (PACU) admission,pain at Post Anesthesia Care Unit (PACU) discharge,need for rescue analgesia intraoperatively,Bromage scale every 3 min after spinal anesthesia,Bromage scale every 15 min,duration of motor block,duration of staying in PACU

Summary

This will be a prospective randomized study, aiming at comparing an intrathecal fixed dose of
 chloroprocaine 1% versus an intrathecal fixed dose of ropivacaine 0.75% in elective cesarean
 sections

ICD-10 classifications
Delivery by elective caesarean sectionDelivery by emergency caesarean sectionDelivery by caesarean section, unspecifiedOther single delivery by caesarean sectionComplication of anaesthesia during labour and delivery, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06376058
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06376058 through Pure Global AI's free database. This phase not specified trial is sponsored by Aretaieion University Hospital and is currently Recruiting. The study focuses on Cesarean Section,Local Anesthetic. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.